Trials / Completed
CompletedNCT03295071
REALITY LHON Registry
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- GenSight Biologics · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a multi-country retrospective and cross-sectional observational study of affected LHON subjects, based on retrospective subjects' medical chart abstractions and cross-sectional administration of patient-reported outcomes (PROs).
Detailed description
The purpose of this study is to understand the evolution of visual functional and structural changes and other associated symptoms in patients with LHON. The relation between genetic, lifestyle and/or environmental factors and the LHON disease will be described, and a better understanding of the natural history of LHON disease and the healthcare associated to with the disease will be sought. In addition, we would also like to understand the economic burden for patients and their families with LHON resulting from direct and indirect costs they may have because of their disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patient-reported outcomes (PROs) | Patient-reported outcomes (PROs) |
Timeline
- Start date
- 2018-01-03
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2017-09-27
- Last updated
- 2026-03-02
Locations
11 sites across 5 countries: United States, France, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03295071. Inclusion in this directory is not an endorsement.